T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies

por Eichenauer, Dennis A., Bühnen, Ina, Fuchs, Michael, Greil, Richard, Moccia, Alden, Zijlstra, Josée. M., Hartmann, Sylvia, Kobe, Carsten, Dietlein, Markus, Engert, Andreas, Borchmann, Peter
Publicado 2022

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma

por Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine
Publicado 2020

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

por Stathis, Anastasios, Mey, Ulrich, Schär, Sämi, Hitz, Felicitas, Pott, Christiane, Mach, Nicolas, Krasniqi, Fatime, Novak, Urban, Schmidt, Christian, Hohloch, Karin, Kienle, Dirk Lars, Hess, Dagmar, Moccia, Alden A., Unterhalt, Michael, Eckhardt, Katrin, Hayoz, Stefanie, Forestieri, Gabriela, Rossi, Davide, Dirnhofer, Stefan, Ceriani, Luca, Sartori, Giulio, Bertoni, Francesco, Buske, Christian, Zucca, Emanuele, Hiddemann, Wolfgang
Publicado 2022

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group

por Borchmann, Peter, Moccia, Alden, Greil, Richard, Herzberg, Mark, Fosså, Alexander, Hüttmann, Andreas, Keil, Felix, Dierlamm, Judith, Schaub, Valdete, Hänel, Mathias, Novak, Urban, Meissner, Julia, Hellmuth, Johannes, Mathas, Stephan, Zijlstra, Josée. M., Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratush, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans Theodor, Baues, Christian, Hallek, Michael, Kobe, Carsten, Diehl, Volker, Engert, Andreas
Publicado 2022